Blake Phillipy’s Post

View profile for Blake Phillipy, graphic

MidSouth District Manager at Medtronic Pain Interventions

For HCPs, the real questions are: For every ten SCS patients, which one WON’T need an MRI? And For every ten SCS patients, which are the five or so who WON’T have impedance issues when they need an MRI? Why guess when you don’t have to? #medtronicemployee #advancingtherapies #enhancingoutcomes #midsouthdistrict

In a recent independent study, 43% of non-Medtronic‡ SCS patients lost MRI eligibility at 5 years due to out-of-range impedances (1). Medtronic SureScan™ SCS systems are not dependent on impedance, ensuring 100% of SCS patients retain unmatched access† to this important diagnostic tool. See risk information: https://bit.ly/3TG3WIf #MDTPainInterventions #MRI #MRIAccess †Under specific conditions. Refer to product labeling for full list of conditions. ‡Abbott, Boston Scientific, and Nevro (1) Mullins CF, Harris S, Pang D. A retrospective review of elevated lead impedances in impedance-dependent magnetic resonance-conditional spinal cord stimulation devices. Pain Pract. 2023;00:1–8

  • No alternative text description for this image
David Rosenfeld

David J. Rosenfeld, MD PLLC at Anesthesiologist/Pain Specialist

6mo

I agree! Why limit what imaging study a patient can get. That said full body 3T would be great. A company that offers that would really be cutting edge.

To view or add a comment, sign in

Explore topics